MIRRA ANDREEVA WINS FRENCH OPEN AT 19, BECOMES YOUNGEST WOMEN’S CHAMPION SINCE MONICA SELES . (PHOTO).
Mirra Andreeva wins French Open at 19, becomes youngest women’s champion since Monica Seles Russian tennis star Mirra Andreeva completed a breakout run at the French Open on Saturday, defeating Polish qualifier Maja Chwalinska 6-3, 6-2 to capture her first Grand Slam title at age 19. Andreeva, who was already regarded as a prodigy after emerging on the WTA Tour as a teenager, became the youngest women’s singles champion since Monica Seles, who was 18 when she won her third straight French Open in 1992. Ranked eighth in the world, she controlled the final in Paris, taking command after dropping just a few early games. The match shifted decisively when Andreeva won nine consecutive games to seize control, eventually closing out the victory with a backhand winner on match point before falling to her knees in celebration on the clay. She finished with 25 winners compared to Chwalinska’s 10 and committed fewer unforced errors in a match played under windy conditions at Cour...
According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.
Comments
Post a Comment